Cargando…
The Rational Use of Complement Inhibitors in Kidney Diseases
The development of complement inhibitors represented one of the major breakthroughs in clinical nephrology in the last decade. Complement inhibition has dramatically transformed the outcome of one of the most severe kidney diseases, the atypical hemolytic uremic syndrome (aHUS), a prototypic complem...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171628/ https://www.ncbi.nlm.nih.gov/pubmed/35685323 http://dx.doi.org/10.1016/j.ekir.2022.02.021 |